Statin Therapy in Ischemia-Reperfusion Injury sustained during a heart attack
Statin Therapy in Ischemia-Reperfusion Injury: A randomised trial to evaluate the effect of high dose rosuvastatin on myocardial infarct size post ST elevation myocardial infarction (STEMI).
SAHMRI
300 participants
Feb 4, 2013
Interventional
Conditions
Summary
The primary purpose of the study is to ascertain whether giving high doses of a cholesterol lowering drug (statin) can reduce the amount of damage caused to the heart by having a lack of oxygen and then having blood restored to the heart quickly when the blocked artery is opened by the insertion of a stent. Tissue damage may be caused when the supply of oxygen is restored to the heart. There are sound biological reasons but limited data that shows that by giving a high dose of a statin drug it is believed that the injury to the heart may be lessened and that incidences of heart failure caused by the heart attack may be lessened.
Eligibility
Inclusion Criteria2
- Symptoms of acute myocardial infarction within 12 hours with ST elevation of more than 1 mm in at least two contigous leads on ECG of new onset Left Bundle Branch Block.
- Provision of written informed consent.
Exclusion Criteria10
- Cardiogenic shock or symptomatic hypotension or sitting SBP < 95 mm Hg
- Previous MI
- Standard CMR contraindications (e.g. pacemaker, severe claustrophobia etc.)
- Known serious or hypersensitivity reactions to statin
- known familial hypercholesterolemia
- known active liver disease or significant renal failure (eGFR < 45 mls/min)
- Non-cardiac comorbidity with life expectation < 1 year.
- Patients who are Filipino, Chinese, Japanese, Korean or Vietnamese.
- Patients taking any of the following cyclosporine, gemfibrozel or fusidic acid.
- Attending consultant intends to use high dose statin therapy, Atorvastatin 80 mgs or Rosuvastatin 40 mgs.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Rosuvastatin 40 mgs orally on randomisation and daily for 5 days post angioplasty. Angioplasty is performed as soon as possible post randomisation.
Locations(5)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12613000032752